Navigation Links
Vital Signs Monitor 300 Series

ProductsVital Signs Monitor 300 Series
Company Welch Allyn Medical Products
Item Vital Signs Monitor 300 Series
Features 
  • The great features youve come to expect from Welch Allyn
  • Separate patient modes with individual settings for adult, pediatric and neonatal support
  • Fast, accurate temperature readings with industry leading Welch Allyn SureTemp Plus thermometry
  • Simple, straightforward operation and intuitive menu navigation with our innovative monitor design
    • Description The Vital Signs Monitor 300 Series enhances your productivity by providing automated vital signs before, during and after procedures. This easy to use portable monitor makes taking automated vital sign readings fast and convenient.

    The Vital Signs Monitor 300 Series begins as a noninvasive blood pressure monitor with the flexibility to add Nellcor® motion-tolerant pulse oximetry, market-leading SureTemp® Plus 4-second thermometry or a built-in printer. With three distinct patient modes adult, pediatric and neonatal your patients of all ages benefit from customized settings and accurate results. The bright display and simple menu functions make the Vital Signs Monitor 300 Series convenient and easy to use. It's ideal for spot check or continuous monitoring in settings ranging from a busy ED to an outpatient clinic. And it's easy to take wherever you need it. Carry it, set it on a countertop, mount it on a wall or wheel it on its own mobile stand
    Info Welch Allyn Medical Products
    Customer Service: (800) 535-6663
    Web site: http://www.welchallyn.com/medical/

    Related medicine products :

    1. M.R.I. Vital Port Systems (standard size)
    2. Titanium Vital Port Systems (standard size)
    3. Petite Titanium Vital Port Systems
    4. Petite M.R.I. Vital Port Systems
    5. Mini Titanium Vital Port Systems
    6. Dual Chamber M.R.I. Vital Port Systems
    7. Dual Chamber Titanium Vital Port Systems
    8. Petite Dual Chamber Titanium Vital Port Systems
    9. Mini Titanium Vital-Port Systems for Peripheral Placement
    10. Vitality DS
    11. Vitality DS VR
    ...e; Elbow and Hand Spasticity Orthosis decreases th...y post-stroke. Treat elbow, forearm, wrist simulta...nt and adjust to meet available passive ROM. Next,...t. Then apply hand cone to the bar. Use included A...
    ...e; Dynamic Elbow Torque Orthosis increases elbow R...a spring-loaded force gauge. Turn adjustment screw...urement on scale on upper-arm component of orthosi... extension using adjustable tabs on goniometer joi...
    ...Cryo/Cuff combines the therapeutic benefits of con...welling, and cold to minimize pain. The cuff is an...oviding maximum cryotherapy. The Elbow Cryo/Cuff i...atric size.,All Cryo/Cuffs can be ordered as a sin...
    ...rade; ROM Elbow Orthosis features aluminum cuffs t...roper joint alignment, unique slot/screw adjustmen...istal adjustments to cuff position. Cuffs are conf...use with contractures.,The hinge can be locked in...
    Medicine Products:
    (Date:11/21/2008)...21, 2008)The University of Texas Health Science Ce...g Excellence in Aging Studies (TEXAS), to promote ...igious $2 million award from the Donald W. Reynold..., "This will allow us to teach geriatric medicine ...l student to practicing physicians. With the reach...
    (Date:11/21/2008)... Nov. 21 The Providence ...nced that Craig A. Norris, the Company,s,Chief Op...,s Board of,Directors. Mr. Norris, appointment f...on of Steven I. Geringer and returns the board to ...mmittee of the Board. , Mr. Norris, age 41,...
    (Date:11/21/2008)...Banzel proved effective against Lennox-Gastaut syn...s) -- A new drug called Banzel (rufinamide) has be...ere form of epilepsy called Lennox-Gastaut syndrom... Friday. , The approval was based on results of...s ages 4 to 30. Compared to patients who took a pl...
    (Date:11/21/2008)...Va., Nov. 21 New resear...her a smokeless, spitless tobacco product aimed at...have found that RJ Reynolds, Camel Snus - touted a... contains surprisingly high levels of nicotine. ,...ost other snuff products," said Bruce Adkins of th...
    Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
    ...ts General Hospital (MGH), published a study-- HIV...immune attack. But once these mutations occur they...mune system by displaying viral protein fragments ...al to kill the infected cell. The immune response ...
    ...rlands Organization for Scientific Research (NWO) ...tter resistance to disease if they took extra zinc...n the past, zinc was largely ignored due to the di...he blood. Scientists now know that zinc deficiency...
    ...om stroke in the US occur among postmenopausal wom...can women at risk be detected?// One way may be t... warning sign of stroke risk is atheroma - fatty d...ng the brain. This can be picked up through a dent...
    ...eened periodically once in 5 years in older people...od test (FOBT) which looks for traces of blood she...on of the lower colon. According to researchers at...ath rate from colon cancer has been decreased due ...
    Other Medicine News:
    (Date:11/20/2008)... The following is being...: , , WHAT: World AIDS Day Audio Media Co...er 25, 2008 , 11:00 a.m. EST , Call-in numbe...https://cc.readytalk.com/r/1xe41i2yre8rs , ,...mber of people newly put on treatment worldwide, a...
    (Date:11/20/2008)... LINE RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIF...ROVEMENT IN DAILY FUNCTION, IN, ...Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewswire...: JAZZ ) and UCB (Euronext Brussels: UCB),annou...rom the first of two,Phase III pivotal clinical t...
    (Date:11/20/2008)... Nov. 20 Bionovo, Inc.,...nt results from the Phase 1B,clinical trial of th...east,cancer, BZL101, at the Society for Integrati...tlanta, Georgia. The Company,s oral presentation ...e presented as a part of the Best of the,SIO Sess...
    (Date:11/20/2008)...PRNewswire/ -- Clinical data from a prospective,r...th Symposium shows DVT,treatment with the Trellis...lar, Inc. (Santa Clara, CA) successfully breaks up...tes. , This technique, called isolated phar...more quickly and safely than current catheter-dire...
    Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Scientists find elephant memories may hold key to survival 4417 1Scientists find elephant memories may hold key to survival 4417 2Scientists find elephant memories may hold key to survival 4417 3SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery 7067 1SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery 7067 2New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating Often Fatal Disease 2816 1New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating Often Fatal Disease 2816 2New Research Shows One in 200 People Born with DNA Mutation That Can Lead to Devastating Often Fatal Disease 2816 3Surviving the revolution easier than withstanding human use and abuse 4415 1Surviving the revolution easier than withstanding human use and abuse 4415 2Surviving the revolution easier than withstanding human use and abuse 4415 3
    ...ineRx Ltd.,(TASE:BLRX), Israel,s leading drug deve...e I trial of BL-1020, the first GABA,enhanced anti...schizophrenia. The trial demonstrated that the com...cal evidence of dopamine,blockade which is indicat... poster (Abstract 235 XX) at the 2007 American Psy...
    ...e of Cardiology,s,Board of Trustees has approved s...rising from his statements that resulted in the,br...go on the,COURAGE trial data presented at American...fic Session in March. ,The Board accepted the reco...Committee to issue a letter of censure to and proh...
    Other Medicine Technology:BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 2BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 3BioLineRx Presents Data From Successful Phase I Trial for BL-1020,in Schizophrenia at American Psychiatric Association Conference 4